Peptide Index
Compare approved and investigational metabolic peptides, including GLP-1, GIP, glucagon and amylin-pathway compounds. Profiles separate product-label evidence from clinical trials, preclinical findings and community reports.
Educational research reference only, not medical advice. Evidence strength and regulatory status vary substantially between compounds.
10 Weight Loss & Metabolic research profiles
No peptide profiles match your search in this category.
5-Amino-1MQ
5-Amino-1MQ is included because peptide clinics and metabolic-stacking discussions often mention it, but chemically it is not a peptide. It is usually discussed as an NNMT inhibitor related to fat-cell metabolism and NAD…
Read profile →Adipotide
Adipotide is not an appetite suppressant, GLP-1, or ordinary “cutting” peptide. It is designed to injure the blood vessels that support white fat. That mechanism is why kidney safety and off-target injury concerns…
Read profile →AOD-9604
AOD-9604 is a modified fragment of human growth hormone intended to isolate fat-metabolism signaling without full hGH activity.
Read profile →Cagrilintide
Cagrilintide is an amylin analog. In the CagriSema combination, it is paired with semaglutide so that one component strengthens satiety/satiation signaling while the GLP-1 component reduces appetite and improves glycemic…
Read profile →Eloralintide
Eloralintide is Lilly's long-acting, once-weekly investigational amylin analog. In human cell assays, it preferentially activates AMY1R over AMY3R and the calcitonin receptor, distinguishing it from GLP-1, GIP, glucagon…
Read profile →HGH Fragment 176-191
HGH Fragment 176-191 is a short C-terminal portion of the growth hormone molecule promoted for fat metabolism. It is not full growth hormone and should not be treated as the same product as AOD-9604.
Read profile →Retatrutide
Retatrutide activates GLP-1, GIP, and glucagon receptors. The glucagon component is the key differentiator from tirzepatide and may contribute to greater energy-expenditure and liver-fat effects, but it may also change…
Read profile →Semaglutide
Semaglutide is a GLP-1 receptor agonist with approved uses in diabetes, obesity/weight management, and cardiovascular-risk contexts depending on product and label. It is not a research peptide in the same sense as…
Read profile →Tesamorelin
Tesamorelin is an approved GHRH analog used to reduce excess visceral abdominal fat in adults with HIV-associated lipodystrophy. It is not simply a generic belly-fat peptide for everyone.
Read profile →Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist approved for type 2 diabetes and chronic weight management, with additional label expansion depending on current product status. It is a prescription drug, not a…
Read profile →